Middle East & Africa Brachytherapy Devices Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The Middle East and Africa Brachytherapy Devices Market size is expected to reach US$ 52.7 Million by 2034 from US$ 32.7 Million in 2025. The market is estimated to record a CAGR of 5.6% from 2026 to 2034.

Executive Summary and Middle East and Africa Brachytherapy Devices Market Analysis:

The MEA faces unique challenges, including limited access to cancer care resources and disparities in healthcare delivery, which create demand for precise and minimally invasive therapies such as brachytherapy.

In Africa, cancer ranks as the fifth leading cause of death. In 2020, more than 1.1 million new cases were reported, with approximately 70% of global cancer deaths occurring in low- and middle-income countries, which collectively receive less than 5% of global resources for cancer care. By 2040, cancer cases in Africa are projected to reach 2.1 million annually, with 1.4 million deaths, highlighting the need for scalable and sustainable oncology solutions. Initiatives such as the Cancer Care Africa programme are focused on improving healthcare access, system resilience, and the delivery of advanced cancer treatments.

In the Gulf and Saudi Arabia, the Zahrawi Group was appointed as the official sales partner for Elekta's brachytherapy products in June 2021, strengthening the availability of state-of-the-art brachytherapy systems in the region. Such strategic partnerships facilitate technology adoption, training of oncology professionals, and expansion of precision cancer care services.

Middle East & Africa Brachytherapy Devices Market: Strategic Insights

Middle East and Africa Brachytherapy Devices Market Segmentation Analysis:

• By Product, the Middle East and Africa Brachytherapy Devices Market is segmented into Seeds, Brachytherapy Afterloaders and Applicators, and Electronic Brachytherapy. The Brachytherapy Afterloaders and Applicators segment dominated the market in 2025.
• By Type, the Middle East and Africa Brachytherapy Devices Market is segmented into High Dose Rate Brachytherapy Implants and Low Dose Rate Brachytherapy Implants. The Low Dose Rate Brachytherapy Implants segment dominated the market in 2025.
• By Application, the Middle East and Africa Brachytherapy Devices Market is segmented into Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, and Others. The Prostate Cancer segment dominated the market in 2025.
• By End-user, the Middle East and Africa Brachytherapy Devices Market is segmented into Hospital and Specialty Clinics, Ambulatory Surgical Centers, and Others. The Hospital and Specialty Clinics segment dominated the market in 2025.

Middle East & Africa Brachytherapy Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa Brachytherapy Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East and Africa Brachytherapy Devices Market Outlook

High-Dose-Rate (HDR) brachytherapy delivers a concentrated dose of radiation directly to the tumor within a short period, reducing treatment time and minimizing exposure to surrounding healthy tissues. This approach supports improved clinical outcomes while enhancing patient convenience through fewer treatment sessions and shorter hospital stays.

HDR brachytherapy is preferred for treating cancers such as prostate, cervical, breast, and gynecological cancers, where accuracy and dose control are essential. The technology allows clinicians to customize radiation delivery based on tumor characteristics, improving treatment effectiveness and lowering the risk of complications. Additionally, HDR procedures are performed on an outpatient basis, which helps healthcare facilities optimize resource utilization and reduce operational costs.

Industry developments highlight this growing trend. In October 2025, ShardaCare Healthcity announced the launch of its High-Dose-Rate (HDR) Brachytherapy Unit, reinforcing its commitment to precision-driven, patient-centric cancer care through advanced technology. Such initiatives reflect the movement toward adopting innovative radiation therapies that align with modern oncology standards. As cancer incidence continues to rise globally, the demand for HDR brachytherapy systems is expected to surge, shaping the future direction of cancer radiotherapy.

Middle East and Africa Brachytherapy Devices Market Country Insights

By country, the Middle East and Africa Brachytherapy Devices Market is segmented into South Africa, Saudi Arabia, the United Arab Emirates, and the Rest of Middle East and Africa. Saudi Arabia held the largest share in 2025.

Hospitals and specialized cancer centers are focusing on precision-driven and minimally invasive treatment solutions to improve patient outcomes and expand access to care.

In April 2024, Varian, a Siemens Healthineers company, announced a collaboration with BaraSeen Medical Company to introduce the country's first Halcyon system at BaraSeen's newly established standalone Batik-X radiation therapy center in Riyadh. The system, equipped with sustainability features, represents a milestone in expanding access to high-quality cancer care while supporting operational efficiency and environmental responsibility.

Strategic collaborations and technology partnerships, including regional agreements with global players like Elekta, are facilitating the adoption of advanced brachytherapy systems.

The Saudi Arabia brachytherapy devices market is growing steadily, driven by rising cancer incidence, technology adoption, infrastructure expansion, and investment in high-quality, patient-centric oncology treatment solutions.

Middle East and Africa Brachytherapy Devices Market Company Profiles

Some of the key players operating in the market include Carl Zeiss Meditec, GE HealthCare Technologies Inc, Elekta AB, Siemens Healthineers AG, Becton Dickinson and Co, Eckert & Ziegler AG, Theragenics Corporation, BEBIG Medical, CIVCO Medical Solutions, and C4 Imaging.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East and Africa Brachytherapy Devices Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise